Top Markets
Coin of the day
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Rangering i aksjer #32815
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Aksjekurs
$2.22
Markedsverdi
$9.03M
Endring (1 dag)
-3.13%
Endring (1 år)
-21.92%
Land
JP
Handel PhoenixBio Co., Ltd. (6190)

Kategori

Pris 6190 pris med markedsverdi på B
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.
6190
$2.22
Markedsverdi av PhoenixBio Co., Ltd.(6190)
Markedsverdi: $9.03M
Per August 2026 har PhoenixBio Co., Ltd. en markedsverdi på $9.03M. Dette gjør PhoenixBio Co., Ltd. til det 32815th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for PhoenixBio Co., Ltd. fra 2016 til 2026
6190 sammenlignet med topp 5 mest populære stocks
Pris på 6190 Eiendel B Markedsverdi for B Resultater
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.
$1,349,586 $9.03M
$5.493T +60,839,048.11%
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.
$1,096,735 $9.03M
$4.464T +49,440,571.21%
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.
$1,019,277 $9.03M
$4.149T +45,948,769.17%
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.
$876,145 $9.03M
$3.566T +39,496,402.60%
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.
$686,955 $9.03M
$2.796T +30,967,740.84%